These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 16731740)

  • 1. Survivin, a cancer target with an emerging role in normal adult tissues.
    Fukuda S; Pelus LM
    Mol Cancer Ther; 2006 May; 5(5):1087-98. PubMed ID: 16731740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting survivin in cancer therapy: fulfilled promises and open questions.
    Pennati M; Folini M; Zaffaroni N
    Carcinogenesis; 2007 Jun; 28(6):1133-9. PubMed ID: 17341657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin: a protein with dual roles in mitosis and apoptosis.
    Wheatley SP; McNeish IA
    Int Rev Cytol; 2005; 247():35-88. PubMed ID: 16344111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin is not only a death encounter but also a survival protein for invading tumor cells.
    Ouhtit A; Matrougui K; Bengrine A; Koochekpour S; Zerfaoui M; Yousief Z
    Front Biosci; 2007 Jan; 12():1260-70. PubMed ID: 17127378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional and post-transcriptional controls of survivin in cancer cells: novel approaches for cancer treatment.
    Zhang M; Yang J; Li F
    J Exp Clin Cancer Res; 2006 Sep; 25(3):391-402. PubMed ID: 17167980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.
    Capalbo G; Rödel C; Stauber RH; Knauer SK; Bache M; Kappler M; Rödel F
    Strahlenther Onkol; 2007 Nov; 183(11):593-9. PubMed ID: 17960333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of survivin in cord blood CD34(+) stem/progenitor cells and its significance].
    Ma YP; Zou P; Xiao J; Huang SA
    Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):238-40. PubMed ID: 12859873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin: an inhibitor of apoptosis in pediatric cancer.
    Fangusaro JR; Caldas H; Jiang Y; Altura RA
    Pediatr Blood Cancer; 2006 Jul; 47(1):4-13. PubMed ID: 16534789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in anti-survivin treatments for cancer.
    Kanwar RK; Cheung CH; Chang JY; Kanwar JR
    Curr Med Chem; 2010; 17(15):1509-15. PubMed ID: 20166933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin as a target for new anticancer interventions.
    Zaffaroni N; Pennati M; Daidone MG
    J Cell Mol Med; 2005; 9(2):360-72. PubMed ID: 15963255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisurvivin oligonucleotides inhibit growth and induce apoptosis in human medullary thyroid carcinoma cells.
    Du ZX; Zhang HY; Gao DX; Wang HQ; Li YJ; Liu GL
    Exp Mol Med; 2006 Jun; 38(3):230-40. PubMed ID: 16819281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splice variants of survivin as potential targets in cancer.
    Sampath J; Pelus LM
    Curr Drug Discov Technol; 2007 Oct; 4(3):174-91. PubMed ID: 17986000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin: potential role in diagnosis, prognosis and targeted therapy of gastric cancer.
    Wang TT; Qian XP; Liu BR
    World J Gastroenterol; 2007 May; 13(20):2784-90. PubMed ID: 17569112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides.
    Xia C; Xu Z; Yuan X; Uematsu K; You L; Li K; Li L; McCormick F; Jablons DM
    Mol Cancer Ther; 2002 Jul; 1(9):687-94. PubMed ID: 12479365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death.
    Malcles MH; Wang HW; Koumi A; Tsai YH; Yu M; Godfrey A; Boshoff C
    Br J Cancer; 2007 Jun; 96(11):1659-66. PubMed ID: 17505517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapy by disabling crossroad signaling networks: the survivin paradigm.
    Altieri DC
    Mol Cancer Ther; 2006 Mar; 5(3):478-82. PubMed ID: 16546961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin is a potential mediator of prostate cancer metastasis.
    Zhang M; Coen JJ; Suzuki Y; Siedow MR; Niemierko A; Khor LY; Pollack A; Zhang Y; Zietman AL; Shipley WU; Chakravarti A
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1095-103. PubMed ID: 20231071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An IAP in action: the multiple roles of survivin in differentiation, immunity and malignancy.
    Zangemeister-Wittke U; Simon HU
    Cell Cycle; 2004 Sep; 3(9):1121-3. PubMed ID: 15326382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The universal character of the tumor-associated antigen survivin.
    Andersen MH; Svane IM; Becker JC; Straten PT
    Clin Cancer Res; 2007 Oct; 13(20):5991-4. PubMed ID: 17947459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.